Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer, an interim safety analysis. A Dutch Colorectal Cancer Group (DCCG) phase III study. [electronic resource]
Producer: 20070702Description: 1523-8 p. digitalISSN:- 0923-7534
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Camptothecin -- administration & dosage
- Capecitabine
- Carcinoma -- drug therapy
- Colorectal Neoplasms -- drug therapy
- Deoxycytidine -- administration & dosage
- Female
- Fluorouracil -- administration & dosage
- Humans
- Irinotecan
- Male
- Middle Aged
- Netherlands
- Organoplatinum Compounds -- administration & dosage
- Oxaliplatin
- Survival Analysis
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.